Malaria is a major public health problem in the nations of Southeast Asia, where malaria management has met great challenges due to the existence of significant knowledge gaps in epidemiology studies, vector biology, and parasitology. While the four projects in this center program are tailored to address these knowledge gaps, each project entails substantial amounts of research that require the use of advanced molecular technologies. However, there is significant deficiency in research capacity in molecular biology in these endemic countries. In recognition of this deficiency at the study sites, this Molecular Biology Core is created to bolster research capacity in molecular biology and provide overall support for the molecular studies of the program. Specifically, we propose to 1) evaluate rapid diagnostic tests for malaria, and develop and validate novel tools such as loop-mediated isothermal amplification (LAMP) for parasite detection in clinical samples and mosquito vectors, 2) develop and validate molecular methods (e.g., DNA barcoding) for malaria vector species identification and detection of single nucleotide polymorphisms (SNPs) responsible for pyrethroid knock-down resistance (kdr) genotypes of major vector species, and 3) establish and implement molecular methods for genotyping malaria parasites, studying parasite population dynamics, and monitoring the prevalence of drug resistance markers. By establishing a centralized molecular facility, this Core will provide efficient and cost-effective support to the projects of this center. A consortium of investigators with significant molecular expertise will collaborate to develop, optimize, and establish standard operation procedures. By providing training in molecular techniques, this Core will serve as a platform for accelerating the transfer of advanced technologies to scientists of the endemic countries, and building up local research capacities.
This core aims to build a central molecular facility to provide technological support to all research projects of this center and help boosting molecular research capacity in the malaria-endemic areas of Southeast Asia.
|Wang, Meilian; Siddiqui, Faiza Amber; Fan, Qi et al. (2016) Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia. Malar J 15:537|
|Liu, Huaie; Feng, Guohua; Zeng, Weilin et al. (2016) A more appropriate white blood cell count for estimating malaria parasite density in Plasmodium vivax patients in northeastern Myanmar. Acta Trop 156:152-6|
|Zhu, Xiaotong; Zhao, Zhenjun; Feng, Yonghui et al. (2016) Genetic diversity of the Plasmodium falciparum apical membrane antigen I gene in parasite population from the China-Myanmar border area. Infect Genet Evol 39:155-62|
|Wang, Qinghui; Zhao, Zhenjun; Zhang, Xuexing et al. (2016) Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia. PLoS One 11:e0151900|
|Wang, Xiaoming; Zhou, Guofa; Zhong, Daibin et al. (2016) Life-table studies revealed significant effects of deforestation on the development and survivorship of Anopheles minimus larvae. Parasit Vectors 9:323|
|MÃ©nard, Didier; Khim, Nimol; Beghain, Johann et al. (2016) A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. N Engl J Med 374:2453-64|
|Hu, Yue; Zhou, Guofa; Ruan, Yonghua et al. (2016) Seasonal dynamics and microgeographical spatial heterogeneity of malaria along the China-Myanmar border. Acta Trop 157:12-9|
|Guo, Suqin; Zhang, Wei; He, Lishan et al. (2016) Rapid evaluation of artesunate quality with a specific monoclonal antibody-based lateral flow dipstick. Anal Bioanal Chem 408:6003-8|
|Xu, Xin; Zhou, Guofa; Wang, Ying et al. (2016) Microgeographic Heterogeneity of Border Malaria During Elimination Phase, Yunnan Province, China, 2011-2013. Emerg Infect Dis 22:1363-70|
|Guo, Suqin; He, Lishan; Tisch, Daniel J et al. (2016) Pilot testing of dipsticks as point-of-care assays for rapid diagnosis of poor-quality artemisinin drugs in endemic settings. Trop Med Health 44:15|
Showing the most recent 10 out of 88 publications